circKCNN2

ncRNA information

ncRNA

circKCNN2

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

None

Biomarker application

Upstream regulatory factor

Not available

Downstream target

miR-520c-3p/MBD2

Differential expression in
recurrence vs. nonrecurrence

Not available

Cancer information

Cancer name

Hepatocellular Carcinoma

Alias

Liver Cancer

Cancer site

Liver

Recurrence type

Recurrence

Clinical information

Overall survival rate of patients with
high ncRNA expression

Up

ncRNA differential expression in
cancer patients vs. health people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available


Recurrence patients

Not available

Recurrence patients male:female

Not available

Recurrence patients age range

Not available

Recurrence mean age

Not available

Sites of recurrence

Not available


Patients without recurrence

Not available

Patients without recurrence male:female

Patients without recurrence age range

Not available

Patients without recurrence mean age

Not available

Research information

PMID

Description

circKCNN2 suppresses the recurrence of hepatocellular carcinoma at least partially via regulating miR-520c-3p

Tissue resource

tissue samples from recurrent and non-recurrent HCC patients

human hepatocellular carcinoma cell lines cell lines Huh7

human hepatocellular carcinoma cell lines cell lines HepG2

human embryonic kidney cell lines HEK-293T

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

the Eastern Hepatobiliary Surgery Hospital

the Eastern Hepatobiliary Surgery Hospital

the Eastern Hepatobiliary Surgery Hospital

the Eastern Hepatobiliary Surgery Hospital

Country

China

China

China

China

Continent

Asia

Asia

Asia

Asia